drugset / Trial / NCT07171710

Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom

NCT07171710

Enrolling by invitation 30 enrolled Tianjin Eye Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

To study the effectiveness of 0.05% cyclosporine A eye drops in combination with smart plug absorbable lacrimal duct plugs in the monotherapy of cyclosporine for SSDE.

Timeline

Start
2024-03-01
Primary completion
2026-03-01
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 0.05 % Other

Indications